Why splenic HSPCs and committed myeloid precursors are more sensitive than their BM counterparts to such treatments is presently unclear
Why splenic HSPCs and committed myeloid precursors are more sensitive than their BM counterparts to such treatments is presently unclear. from the spleen and compromises… Read More »Why splenic HSPCs and committed myeloid precursors are more sensitive than their BM counterparts to such treatments is presently unclear